Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Perennial Allergic Rhinoconjunctivitis”

28 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 28 results

Testing effectiveness (Phase 2)Study completedNCT01008332
What this trial is testing

Safety of ToleroMune House Dust Mite (HDM) to Treat House Dust Mite Allergy in HDM Allergic Subjects With Rhinoconjunctivitis

Who this might be right for
Allergy
Circassia Limited 50
Testing effectiveness (Phase 2)Study completedNCT00575003
What this trial is testing

Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergy to House Dust Mite and/or Cat
Cytos Biotechnology AG 64
Testing effectiveness (Phase 2)Study completedNCT00574223
What this trial is testing

Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Cytos Biotechnology AG 100
Testing effectiveness (Phase 2)Study completedNCT00652223
What this trial is testing

Effect of an Allergen Vaccine in Patients With Allergic Rhino-Conjunctivitis and Asthma Due to House Dust Mite Allergy

Who this might be right for
Perennial Allergic RhinoconjunctivitisAllergic Asthma
Cytos Biotechnology AG 21
Large-scale testing (Phase 3)Not Yet RecruitingNCT05641272
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract

Who this might be right for
Allergic RhinitisAllergic AsthmaAllergic Rhinoconjunctivitis+1 more
Inmunotek S.L. 90
Not applicableStudy completedNCT03127436
What this trial is testing

Non-interventional Study to Assess the Tolerability and the Safety Profile of SCIT Therapy With Acarovac® Hausstaubmilbe

Who this might be right for
Perennial Allergic Rhinitis
University Hospital of Cologne 32
Large-scale testing (Phase 3)Study completedNCT01700192
What this trial is testing

Efficacy and Safety Study of SCH 900237/MK-8237 in Children and Adults With House Dust Mite-Induced Allergic Rhinitis/Rhinoconjunctivitis (P05607)

Who this might be right for
Rhinitis, Allergic, PerennialRhinitis, Allergic, Nonseasonal
ALK-Abelló A/S 1,482
Large-scale testing (Phase 3)Study completedNCT06920771
What this trial is testing

A Randomized, Double-Blind, Placebo-Controlled, Multi-Centre Study to Assess the Efficacy of PURETHAL Mites Mixture 50,000 AUeq/mL Subcutaneous Immunotherapy in Adult Subjects With Moderate to Severe Allergic Rhinitis/Rhinoconjunctivitis With or Without Asthma Induced by House Dust Mite (HDM)

Who this might be right for
House Dust Mite AllergyHouse Dust Mite Rhinitis
HAL Allergy 691
Not applicableStudy completedNCT01923792
What this trial is testing

ToleroMune House Dust Mite Follow on Study

Who this might be right for
House Dust Mite AllergyRhinoconjunctivitis
Circassia Limited 105
Large-scale testing (Phase 3)Study completedNCT00623701
What this trial is testing

Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation

Who this might be right for
AllergyRhinitisConjunctivitis
Allergopharma GmbH & Co. KG 126
Testing effectiveness (Phase 2)Study completedNCT03094845
What this trial is testing

Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients

Who this might be right for
House Dust Mite Allergy
ASIT Biotech S.A. 36
Large-scale testing (Phase 3)Looking for participantsNCT07348302
What this trial is testing

Efficacy and Safety of SLIT in Patients With Rhinitis/RC With/Without Mild-moderate Asthma, Due to Dpt and/or Df

Who this might be right for
RhinitisRhinoconjunctivitis
Inmunotek S.L. 736
Testing effectiveness (Phase 2)Study completedNCT00574704
What this trial is testing

Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

Who this might be right for
Perennial Allergic RhinoconjunctivitisHouse Dust Mite Allergy
Cytos Biotechnology AG 40
Not applicableStudy completedNCT07427576
What this trial is testing

Retrospective Study Evaluating the Effectiveness and Safety of Immunotherapy With Clustoid Max Forte

Who this might be right for
Mite AllergyDermatophagoides Farinae AllergyDermatophagoides Pteronyssinus Allergy+3 more
Inmunotek S.L. 140
Large-scale testing (Phase 3)Study completedNCT03599791
What this trial is testing

DYmista NAsal Spray in CHInese Patients

Who this might be right for
Allergic Rhinitis
MEDA Pharma GmbH & Co. KG 900
Post-approval studies (Phase 4)Study completedNCT00263549
What this trial is testing

Safety and Efficacy of House Dust Mite Allergen Extract in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
House Dust Mite Allergy
Allergopharma GmbH & Co. KG
Large-scale testing (Phase 3)UnknownNCT05400811
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis

Who this might be right for
House Dust Mite AllergyPerennial Allergic RhinitisAllergic Rhinoconjunctivitis+1 more
Inmunotek S.L. 400
Large-scale testing (Phase 3)Ended earlyNCT04874714
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis

Who this might be right for
Allergic RhinoconjunctivitisPerennial Allergic RhinitisHouse Dust Mite Allergy+1 more
Inmunotek S.L. 18
Large-scale testing (Phase 3)Study completedNCT01127620
What this trial is testing

Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety Extension

Who this might be right for
Perennial Allergic Rhinitis
Faes Farma, S.A. 650
Large-scale testing (Phase 3)Study completedNCT00263640
What this trial is testing

Safety and Efficacy of House Dust Mite Allergoid in the Treatment of Bronchial Asthma

Who this might be right for
Respiratory Hypersensitivity
Allergopharma GmbH & Co. KG 130
Next Page